Skip to content
Review Open access

Skin physiologically based pharmacokinetic modeling: current research progress, software comparison, and future perspectives

Sep 2026 · Drug Delivery · Vol 33 · 0 citations · 116 references
Medicine

TL;DR

Simcyp provides a refined depiction of skin physiological structure and is widely applied in clinical evaluation and special population prediction and Skin-CAD focuses more on the mechanistic description of TDS formulations, while GastroPlus focuses more on the mechanistic description of TDS formulations.

Abstract

Abstract Transdermal and topical delivery systems (TDS) have emerged as the third-largest route of administration due to their ability to bypass first-pass metabolism and maintain stable plasma concentrations. Skin physiologically based pharmacokinetic (PBPK) models mechanistically characterize the percutaneous absorption process, predict local and systemic exposure, and enhance research and development efficiency through virtual clinical trials. This paper first elaborates on the theoretical foundation of skin PBPK modeling based on Fick's second law of diffusion and compares the model assumptions and application scenarios of four well-established and validated modeling platforms: Simcyp, GastroPlus, Skin-CAD, and PK-Sim. The findings indicate that Simcyp provides a refined depiction of skin physiological structure and is widely applied in clinical evaluation and special population prediction. GastroPlus focuses more on the mechanistic description of TDS formulations. Skin-CAD, as a specialized software, is extensively utilized for in vitro–in vivo extrapolation (IVIVE) predictions and formulation optimization. PK-Sim, as a freely accessible open-source software, has been used to investigate the physiological ontogeny of skin in pediatric populations. However, existing studies share limitations such as highly inconsistent model structures with varying complexity, challenges in acquiring accurate parameters, and a scarcity of physiological information for special populations. Future research should prioritize optimizing parameter acquisition methods and broadening physiological databases for pediatric, geriatric, and skin-lesion populations. Additionally, integrating non-invasive imaging technologies to construct high-precision ‘digital twin’ skin models represents a critical future direction. These advancements will drive the transition of PBPK models from descriptive tools to supportive instruments for individualized dosing and regulatory decision-making.

Read PDF

Similar papers

Review Oct 2026

Pharmacokinetic evaluation of inhaled formulations: from in vitro models to clinical assessment.

Pulmonary drug delivery systems (PDDS) represent a strategic approach for the localized treatment of respiratory diseases and the systemic administration of biotherapeutics due to their unique physiological advantages. Pharmacokinetic (PK) evaluation serves as the essential link between formulation engineering and clin...

Chang Ren, Yi-Mou Zhang, Yu Zhang et al. · 0 citations
Review Open access Sep 2026

Pharmacokinetic Relevance of In Vitro Skin Models: Absorption, Cutaneous Distribution, Metabolism, and Clearance-like Removal in Dermal and Transdermal Drug Testing

Background: In vitro skin models are widely used in dermal and transdermal drug development, yet their pharmacokinetic interpretation often remains endpoint-dependent and does not fully capture cutaneous disposition, including partitioning, local metabolism, or clearance-like removal. This review evaluates the utility...

Filip Dugonik, Urška Jeršič, Lejla Kač et al. · 0 citations
Review Open access Oct 2026

From Empirical Correlation to Mechanistic Modeling: The Changing Landscape of IVIVC Approaches for Oral Modified-Release Drug Products

In vitro–in vivo correlation (IVIVC) is an important tool in the development, quality evaluation, and regulatory assessment of oral modified-release (MR) drug products. By establishing a quantitative relationship between in vitro dissolution and in vivo drug absorption, IVIVC provides a scientific basis for formulation...

Zheng-Nan Huang, Jie Yin, Yao Qiao et al. · 0 citations
Review Open access Sep 2026

Development and Evaluation of Physiologically Based Pharmacokinetic (PBPK) Models of Metoclopramide Across the Lifespan: Translation from Adults to Infants

Background: Physiologically based pharmacokinetic (PBPK) modeling is an established approach used in recent years for estimating drug disposition in challenging clinical scenarios where in vivo studies are difficult to perform. Metoclopramide is a benzamide derivative, widely indicated for its antiemetic and prokinetic...

Iqra Shahzad, A. Zamir, M. Rasool et al. · 0 citations
Open access Oct 2026

A Dual Mechanism-Based Physiologically Based Pharmacokinetic Model for Predicting Mitoxantrone and Liposomal Mitoxantrone Disposition: Preclinical Validation in Rats and Human Extrapolation with Clinical Evaluation

Purpose This study aimed to develop a physiologically based pharmacokinetic (PBPK) model to quantitatively predict plasma and tissue concentrations of both liposomal-encapsulated and free mitoxantrone in rats and further extrapolate the model to human clinical scenarios. Methods A dual-compartment PBPK framework was co...

Yu-Xiang Xu, Shuo Li, Zhi-Xuan Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.